{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:04:29Z","timestamp":1792710269146,"version":"4.5.0"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T00:00:00Z","timestamp":1363564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0059210","type":"journal-article","created":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T20:59:33Z","timestamp":1363640373000},"page":"e59210","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses"],"prefix":"10.1371","volume":"8","author":[{"given":"Weidong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret C.","family":"Costanzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon A.","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sidney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew K.","family":"Sewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Wooldridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarence J.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Kan-Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1128\/JVI.02641-10","article-title":"Rift valley fever: recent insights into pathogenesis and prevention","volume":"85","author":"H Boshra","year":"2011","journal-title":"J Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.59.3.305","article-title":"Rift Valley Fever in Man : Report of a Fatal Laboratory Infection Complicated by Thrombophlebitis","volume":"59","author":"FF Schwentker","year":"1934","journal-title":"The Journal of experimental medicine"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.62.3.433","article-title":"Rift Valley Fever : A Report of Three Cases of Laboratory Infection and the Experimental Transmission of the Disease to Ferrets","volume":"62","author":"T Francis","year":"1935","journal-title":"The Journal of experimental medicine"},{"key":"ref4","first-page":"213","article-title":"Rift Valley fever; accidental infections among laboratory workers","volume":"62","author":"KC Smithburn","year":"1949","journal-title":"J Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.ijid.2009.03.029","article-title":"Manifestations of severe Rift Valley fever in Sudan","volume":"14","author":"AA Adam","year":"2010","journal-title":"Int J Infect Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/vetres\/2010033","article-title":"Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention","volume":"41","author":"M Pepin","year":"2010","journal-title":"Vet Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"L Borio","year":"2002","journal-title":"JAMA : the journal of the American Medical Association"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"D69","DOI":"10.1016\/j.vaccine.2009.07.046","article-title":"Rift valley fever vaccines","volume":"27","author":"T Ikegami","year":"2009","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0264-410X(99)00218-2","article-title":"Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience","volume":"18","author":"PR Pittman","year":"1999","journal-title":"Vaccine"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"R Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"10)","author":"H Caplen","year":"1985","journal-title":"J Gen Virol 66 (Pt"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep","volume":"28","author":"B Dungu","year":"2010","journal-title":"Vaccine"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"JC Morrill","year":"1991","journal-title":"Vaccine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"JC Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"JC Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/infdis\/jir354","article-title":"Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine","volume":"204","author":"JC Morrill","year":"2011","journal-title":"J Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","article-title":"Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys","volume":"21","author":"JC Morrill","year":"2003","journal-title":"Vaccine"},{"key":"ref18","first-page":"808","article-title":"A rift Valley fever vaccine trial. I. Side effects and serologic response over a six-month follow-up","volume":"116","author":"JD Kark","year":"1982","journal-title":"Am J Epidemiol"},{"key":"ref19","unstructured":"Metwally S (2008) Foreign Animal Diseases.; Brown C, Torres, A., editor. Boca Raton, FL: Boca Publications Group, Inc."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1099\/vir.0.2008\/002097-0","article-title":"T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus","volume":"89","author":"M Habjan","year":"2008","journal-title":"J Gen Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene","volume":"80","author":"T Ikegami","year":"2006","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Heise MT, Whitmore A, Thompson J, Parsons M, Grobbelaar AA, <etal>et al<\/etal>.. (2009) An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus. Epidemiol Infect: 1\u201310.","DOI":"10.1017\/S0950268808001696"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1089\/vbz.2009.0248","article-title":"Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus","volume":"10","author":"A Pichlmair","year":"2010","journal-title":"Vector Borne Zoonotic Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1875035401003010114","article-title":"Evaluation of a Recombinant Rift Valley Fever Virus Subunit Nucleocapsid Protein as an Immunogen in Mice and Sheep","volume":"3","author":"PJ van Vuren","year":"2010","journal-title":"The Open Vaccine Journal"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jviromet.2006.11.005","article-title":"Preparation and evaluation of a recombinant Rift Valley fever virus N protein for the detection of IgG and IgM antibodies in humans and animals by indirect ELISA","volume":"140","author":"JP van Vuren","year":"2007","journal-title":"J Virol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jviromet.2007.06.006","article-title":"Validation of an indirect ELISA based on a recombinant nucleocapsid protein of Rift Valley fever virus for the detection of IgG antibody in humans","volume":"146","author":"JT Paweska","year":"2007","journal-title":"J Virol Methods"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.vetmic.2006.11.008","article-title":"Cloning and expression of Rift Valley fever virus nucleocapsid (N) protein and evaluation of a N-protein based indirect ELISA for the detection of specific IgG and IgM antibodies in domestic ruminants","volume":"121","author":"JM Fafetine","year":"2007","journal-title":"Veterinary Microbiology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jviromet.2011.07.011","article-title":"Validation of an IgM antibody capture ELISA based on a recombinant nucleoprotein for identification of domestic ruminants infected with Rift Valley fever virus","volume":"177","author":"R Williams","year":"2011","journal-title":"J Virol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2006.06.041","article-title":"Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever","volume":"24","author":"DB Wallace","year":"2006","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e25027","DOI":"10.1371\/journal.pone.0025027","article-title":"Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice","volume":"6","author":"PJ van Vuren","year":"2011","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1743-422X-6-6","article-title":"Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs","volume":"6","author":"N Lagerqvist","year":"2009","journal-title":"Virol J"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1016\/j.vaccine.2008.07.042","article-title":"Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep","volume":"26","author":"G Lorenzo","year":"2008","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1016\/j.vaccine.2010.02.018","article-title":"Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(\u2212\/\u2212) mice induced by different DNA vaccination regimens","volume":"28","author":"G Lorenzo","year":"2010","journal-title":"Vaccine"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Boshra H, Lorenzo G, Rodriguez F, Brun A (2011) A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(\u2212\/\u2212) mice upon lethal virus challenge. Vaccine.","DOI":"10.1016\/j.vaccine.2011.04.043"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"JT Harty","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.4049\/jimmunol.172.9.5249","article-title":"The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope","volume":"172","author":"J Kan-Mitchell","year":"2004","journal-title":"J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.4049\/jimmunol.176.11.6690","article-title":"Degeneracy and repertoire of the human HIV-1 Gag p17(77\u201385) CTL response","volume":"176","author":"J Kan-Mitchell","year":"2006","journal-title":"J Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.4049\/jimmunol.178.12.7756","article-title":"Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419\u201327 epitope","volume":"178","author":"KL Schaubert","year":"2007","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/j.1460-2075.1986.tb04307.x","article-title":"Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid","volume":"5","author":"RD Salter","year":"1986","journal-title":"Embo J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"32786","DOI":"10.1074\/jbc.M102498200","article-title":"The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain","volume":"276","author":"MA Purbhoo","year":"2001","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0198-8859(01)00319-6","article-title":"Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules","volume":"62","author":"J Sidney","year":"2001","journal-title":"Hum Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"27491","DOI":"10.1074\/jbc.M500555200","article-title":"Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface","volume":"280","author":"L Wooldridge","year":"2005","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"J Alexander","year":"1994","journal-title":"Immunity"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/infdis\/jir249","article-title":"Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus","volume":"204","author":"JC Morrill","year":"2011","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood.V96.4.1327","article-title":"Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro","volume":"96","author":"A Gruber","year":"2000","journal-title":"Blood"},{"key":"ref46","unstructured":"Sidney J, Southwood S, Oseroff C, Del Guercio MF, Sette A, <etal>et al<\/etal>.. (1998) Measurement of MHC\/peptide interactions by gel filtration Current protocols in immunology: Wiley, New York. pp. pp 18.13.11\u201318.13.19."},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/eji.200940079","article-title":"Generation of robust CD8(+) T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes","volume":"40","author":"KL Schaubert","year":"2010","journal-title":"Eur J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e1000798","DOI":"10.1371\/journal.ppat.1000798","article-title":"Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells","volume":"6","author":"G Makedonas","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.it.2005.07.005","article-title":"Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer","volume":"26","author":"F Kern","year":"2005","journal-title":"Trends Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"MR Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood-2002-03-0926","article-title":"Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice","volume":"100","author":"C La Rosa","year":"2002","journal-title":"Blood"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1172\/JCI58653","article-title":"A high-throughput single-cell analysis of human CD8(+) T cell functions reveals discordance for cytokine secretion and cytolysis","volume":"121","author":"N Varadarajan","year":"2011","journal-title":"J Clin Invest"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.4049\/jimmunol.153.12.5586","article-title":"The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes","volume":"153","author":"A Sette","year":"1994","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/eji.200838815","article-title":"Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model","volume":"39","author":"M Moutaftsi","year":"2009","journal-title":"Eur J Immunol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.4049\/jimmunol.170.6.2977","article-title":"Quantifying recruitment of cytosolic peptides for HLA class I presentation: impact of TAP transport","volume":"170","author":"D Fruci","year":"2003","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.200737832","article-title":"Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide-MHC class I complexes","volume":"38","author":"SM Thirdborough","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2008.04.010","article-title":"Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection","volume":"28","author":"JJ Obar","year":"2008","journal-title":"Immunity"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2567.2011.03510.x","article-title":"Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection","volume":"134","author":"JM Ertelt","year":"2011","journal-title":"Immunology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.virol.2009.11.001","article-title":"A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge","volume":"397","author":"RB Mandell","year":"2010","journal-title":"Virology"},{"key":"ref62","first-page":"a007252","article-title":"Vaccine design for CD8 T lymphocyte responses","volume":"1","author":"RA Koup","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"939860","DOI":"10.1155\/2011\/939860","article-title":"Induction of virus-specific cytotoxic T lymphocytes as a basis for the development of broadly protective influenza vaccines","volume":"2011","author":"ML Hillaire","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.micinf.2011.01.007","article-title":"Immunity to seasonal and pandemic influenza A viruses","volume":"13","author":"SA Valkenburg","year":"2011","journal-title":"Microbes Infect"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1099\/0022-1317-68-2-433","article-title":"Purified influenza virus nucleoprotein protects mice from lethal infection","volume":"2)","author":"DC Wraith","year":"1987","journal-title":"J Gen Virol 68 (Pt"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"SL Epstein","year":"2005","journal-title":"Vaccine"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"SA Plotkin","year":"2010","journal-title":"Clinical and vaccine immunology : CVI"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nri891","article-title":"Antibodies, viruses and vaccines","volume":"2","author":"DR Burton","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","article-title":"Contributions of humoral and cellular immunity to vaccine-induced protection in humans","volume":"411","author":"IJ Amanna","year":"2011","journal-title":"Virology"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Greenbaum J, Sidney J, Chung J, Brander C, Peters B, <etal>et al<\/etal>.. (2011) Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics.","DOI":"10.1007\/s00251-011-0513-0"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1073\/pnas.1001760107","article-title":"Structure of the Rift Valley fever virus nucleocapsid protein reveals another architecture for RNA encapsidation","volume":"107","author":"DD Raymond","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","unstructured":"Schmaljohn CS, Hooper JW (2001) Bunyaviridae: the viruses and their replication. In: Knipe DM, Howley, P., Griffin, D E., Martin M A., Lamb R A., Roizman B., and Straus S E., editor. Fields Virology, 4th ed. Philadelphia, PA: Lippincott, Williams &amp; Wilkins."},{"key":"ref73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vetmic.2007.07.031","article-title":"Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo","volume":"127","author":"JT Paweska","year":"2008","journal-title":"Vet Microbiol"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4161\/mabs.2.3.11676","article-title":"Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization","volume":"2","author":"R Martin-Folgar","year":"2010","journal-title":"mAbs"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.4049\/jimmunol.181.6.4168","article-title":"A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus","volume":"181","author":"DM Carragher","year":"2008","journal-title":"J Immunol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1128\/JVI.00150-11","article-title":"Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance","volume":"85","author":"MW Lamere","year":"2011","journal-title":"J Virol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.4049\/jimmunol.1003057","article-title":"Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus","volume":"186","author":"MW LaMere","year":"2011","journal-title":"J Immunol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3109\/03009734.2011.624649","article-title":"The type I interferon system in the etiopathogenesis of autoimmune diseases","volume":"116","author":"L Ronnblom","year":"2011","journal-title":"Ups J Med Sci"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"M Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01316748","article-title":"Topological mapping of antigenic sites on the Rift Valley fever virus envelope glycoproteins using monoclonal antibodies","volume":"121","author":"TG Besselaar","year":"1991","journal-title":"Arch Virol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/infdis\/jiq004","article-title":"Sequential rift valley Fever outbreaks in eastern Africa caused by multiple lineages of the virus","volume":"203","author":"L Nderitu","year":"2011","journal-title":"J Infect Dis"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of Rift Valley fever virus","volume":"95","author":"T Ikegami","year":"2012","journal-title":"Antiviral Res"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1002\/eji.201190072","article-title":"HIV-1: from escapism to conservatism","volume":"41","author":"T Hanke","year":"2011","journal-title":"European journal of immunology"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nm0703-874","article-title":"HIV vaccines 1983\u20132003","volume":"9","author":"AJ McMichael","year":"2003","journal-title":"Nat Med"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.20090365","article-title":"The first T cell response to transmitted\/founder virus contributes to the control of acute viremia in HIV-1 infection","volume":"206","author":"N Goonetilleke","year":"2009","journal-title":"J Exp Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"TM Wilkinson","year":"2012","journal-title":"Nat Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0059210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T16:34:37Z","timestamp":1715099677000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0059210"}},"subtitle":[],"editor":[{"given":"Kylene","family":"Kehn-Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,18]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0059210","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,18]]}}}